Dendritic-antineoplastic drug delivery system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7005124
APP PUB NO 20030064050A1
SERIAL NO

10016733

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Antineoplastic dendritic polymer conjugates which are useful drug delivery systems for carrying antineoplastic agents to malignant tumors are prepared by obtaining a dendritic polymer having functional groups which are accessible to an antineoplastic agent capable of interacting with the functional groups, and contacting the dendritic polymer with the antineoplastic agent. The preferred platin-based analogues of the antineoplastic agents conjugated to the dendritic polymer may be administered intravenously, orally, parentally, subcutaneously, intramuscularly, intraarterially or topically to an animal having a malignant tumor in an amount which is effective to inhibit growth of the malignant tumor. The antineoplastic dendritic polymer conjugates exhibit high drug efficiency, high drug carrying capacity, good water solubility, good stability on storage, reduced toxicity, and improved anti-tumor activity in vivo.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DENDRITIC NANOTECHNOLOGIES INC2625 DENISON DRIVE SUITE B M T PLEASANT MI 48858

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Duncan, Ruth London, GB 15 265
Esfand, Roseita Mt. Pleasant, MI 24 294
Malik, Navid London, GB 5 38
Tomalia, Donald A Midland, MI 72 4037

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation